700-500DX
Cardiva Vascade Vascular Closure System 5F
$12.00
eaches
In Stock: 53 Eaches
Expiration:
Expired
Express: Need it tomorrow? Order in next 2 hours 8 minutes and choose overnight shipping at checkout.
The item listed above is expired and may be used for educational, training, and non-clinical research purposes only. Any product information appearing below, including the product indication statement, pertains to an in-date item only.
Description
Haemonetics Cardiva Vascade VCS
The Vascade Vascular Closure System is indicated for femoral arterial access site closure post-diagnostic and/or interventional endovascular procedures.
Additional Details
- Company Name: Cardiva Medical, Inc.
- FDA Product Code: MGB
- FDA Product Code Name: Device, Hemostasis, Vascular
- GMDN Term Code: 60710
- GMDN Term Name: Femoral artery closure plug/patch, collagen
- GMDN Term Definition: An implantable, bioabsorbable device designed for haemostasis/closure of a puncture site, through pressure/compression, on a patient having undergone femoral artery catheterization; it is intended as an alternative to manual compression or surgical techniques to reduce the time to haemostasis. It consists of an animal-derived collagen plug that is implanted using an included delivery device (e.g., guidewire, hand-held delivery unit) onto the extravascular surface of the femoral artery access site (top of arteriotomy site), and may be held in place with an included synthetic, bioabsorbable patch/anchor/suture to achieve haemostasis.
Additional information
| Size | 5.0F |
|---|---|
| Arms | N/A |
| Manufacturer | |
| Unit | eaches |
- FDA Product Code: MGB
- FDA Product Code Name: DEVICE, HEMOSTASIS, VASCULAR
- GMDN Term Code: 60710
- GMDN Term Name: Femoral artery closure plug/patch, collagen
- GMDN Term Description: An implantable, bioabsorbable device designed for haemostasis/closure of a puncture site, through pressure/compression, on a patient having undergone femoral artery catheterization; it is intended as an alternative to manual compression or surgical techniques to reduce the time to haemostasis. It consists of an animal-derived collagen plug that is implanted using an included delivery device (e.g., guidewire, hand-held delivery unit) onto the extravascular surface of the femoral artery access site (top of arteriotomy site), and may be held in place with an included synthetic, bioabsorbable patch/anchor/suture to achieve haemostasis.
